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Abstract ErbB3 binding protein Ebp1 has been shown to
downregulate ErbB3 receptor-mediated signaling to inhibit
cell proliferation. Rinderpest virus belongs to the family
Paramyxoviridae and is characterized by the presence of a
non-segmented negative-sense RNA genome. In this work,
we show that rinderpest virus infection of Vero cells leads
to the down-regulation of the host factor Ebp1, at both the
mRNA and protein levels. Ebp1 protein has been shown to
co-localize with viral inclusion bodies in infected cells, and
it is packaged into virions, presumably through its inter-
action with the N protein or the N-RNA itself. Over-
expression of Ebp1 inhibits viral transcription and
multiplication in infected cells, suggesting that a mutual
antagonism operates between host factor Ebp1 and the
virus.
Introduction
Rinderpest virus (RPV) belongs to the genus Morbillivirus in
the family Paramyxoviridae, a family of non-segmented
negative-sense RNA viruses that also includes certain human
pathogens such as measles virus and parainfluenza virus. The
viral genome is 15,882 bases in length, coding for structural
proteins in the following order: 30-leader-N–P-M-F–H–L-
trailer-50 [4]. The viral genomic RNA is encapsidated by the
nucleocapsid protein N to form a helical N-RNA that serves
as the template for both transcription and replication [9].
During transcription, the viral N-RNA directs the synthesis
of all species of viral mRNA by the virion-associated RNA-
dependent RNA polymerase (L-P complex), which are
translated to produce viral proteins. During replication, a
full-length complement of the genomic RNA is made and
encapsidated by the newly synthesized N protein, which in
turn acts as the template for the synthesis of viral genome.
Ebp1 was originally identified as an ErbB3-binding
protein that gets translocated to the nucleus upon receptor
activation by heregulin [24]. Knockdown of Ebp1 in mice
as well in Arabidopsis thaliana results in a dwarfism
phenotype at earlier stages of growth, suggesting the
involvement of Ebp1in development [13, 26]. Ebp1 has
been shown to be downregulated in many cancer cell types,
and overexpression of Ebp1 in breast and prostate cancer
cell lines leads to the inhibition of cell growth by pro-
moting G2/M cell-cycle arrest. Ebp1 exerts its anti-prolif-
erative activity by repressing the transcription of
E2F1-regulated cell-cycle-associated genes in association
with RB, HDAC2 and Sin3A, and Ebp1 phosphorylation at
Ser 363 has been shown to be essential for this function
[10]. In addition, Ebp1 was also shown to bind RNA by its
association with the bcl-2 mRNP complex and FMDV IRES
in conjunction with polypyrimidine-tract-binding protein
(PTB) [6, 19]. However, a role for Ebp1 in regulating virus
replication was reported recently by Honda et al. [12], who
demonstrated the selective inhibition of influenza virus
transcription by Ebp1, both in infected cells and in vitro,
without affecting the cap-binding and endonuclease prop-
erties of the viral polymerase. In addition, overexpression of
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Ebp1 was shown to result in reduction of virus titers. Ebp1
was shown to be localized to the nuclear membrane in
association with the PB1 subunit of the polymerase in
infected cells [11, 12]. However, there are no reports on the
role of Ebp1 on the transcription process in members of the
order Mononegavirales. In the present work, we show that
Ebp1 is downregulated upon RPV infection, and over-
expression of Ebp1 inhibits genome transcription as well as
virus replication, suggesting an antagonistic role of Ebp1 in
the negative-sense RNA virus life cycle.
Materials and methods
Cells, viruses and antibodies
The Vero cell line, an African green monkey kidney cell
line, was obtained from the National Centre for Cell Sci-
ence, Pune, India, and maintained in DMEM supplemented
with 10% fetal calf serum. Spodoptera frugiperda (Sf21)
insect cells were obtained from the National Centre for Cell
Science, Pune, India, and maintained in TC-100 medium
(GIBCO-BRL, USA) with 10% fetal calf serum. A tissue
culture-adapted vaccine strain, RBOK, which is the origi-
nal attenuated Kabete ‘O’ strain of RPV, was obtained
from the Institute for Animal Health and Veterinary Bio-
logicals, Bangalore, India. Polyclonal antibodies were
prepared by immunizing rabbits with recombinant Ebp1
protein purified from extracts of Sf21 cells infected with
recombinant baculovirus expressing Ebp1 [12]. A mouse
monoclonal antibody specific for the nucleocapsid protein
of RPV (F8D3) generated earlier in the laboratory (Suresh
K.B., Rajasekhar M. and Shaila, M.S., unpublished) was
employed in an immuno-colocalisation experiment. For
virus production, confluent Vero cells were infected with
RPV at an moi of 1, and virus released into the supernatant
and cell-associated virus were pooled after 96 h of incu-
bation at 37C and purified according to Ghosh et al. [8].
Ebp1 mRNA levels in RPV-infected cells
Vero cells in 35-mm dishes were infected with RPV at an
MOI of 5. At 0, 12, 24, 36, 48 and 60 h postinfection, total
RNA that was free from genomic DNA was isolated using
SV Total RNA Isolation System (Promega, USA) accord-
ing to the manufacturer’s instructions. Equal amounts of
total RNA (4 lg) were resolved by 1.5% MOPS-formal-
dehyde agarose gel electrophoresis, transferred to a nylon
membrane and UV cross-linked. Generation of 32P-labeled
negative-sense RNA probes against RPV N and H mRNA
has been described earlier [9]. For making a cDNA probe
against Ebp1, Ebp1 ORF was released from pCAGGS-
Ebp1 by EcoRI digestion and labeled with [a-32P] ATP
using a HexalabelTM DNA Labeling Kit (Fermentas, USA).
Unincorporated label was removed from the probe by
passing it through Sephadex G50 columns. The Ebp1
cDNA probe was then denatured at 95C for 5 min and
hybridized to the blot at 60C overnight in hybridization
buffer (50% formamide, 6X SSC, 1% SDS, 5X Denhardt’s
solution, 50 lg/ml of sheared herring sperm DNA). The
hybridized blot was exposed to phosphorimaging plates
after washing three times with 0.5X SSC and 0.1% SDS.
For real-time quantification of Ebp1 mRNA, 2 lg of
total RNA was reverse transcribed in 1X RT buffer
(Fermentas) containing 2 mM dNTP and 20 U of human
placental RNAse inhibitor. The cDNA was further diluted
tenfold with water, and 2 ll of the diluted cDNA was used
along with the Ebp1-specific primer pair (Ebp1F: 50-GA
CGAGCAACAGGAGCAAACT-30 and Ebp1 R- 50-CT
TCCACCAAGGACCGAAGT-30) and SYBR Green qPCR
master mix in a total reaction volume of 10 ll. To nor-
malize gene expression, a parallel amplification of an
endogenous (GAPDH) gene was performed with specific
primers (GAPDHF: 50-CATGAG AAGTATGACAA
CAGCCT-30 and GAPDHR: 50-AGTCCTTCCACGAT
ACCAAAGT-30). Real-time PCR was carried out in an
ABI Prism 7700 (PE Applied Biosystems). Relative
quantification of Ebp1 was performed by comparing the
DCt values after normalizing against GAPDH control,
using the SDS 2.1 software (ABI Prism). The results are the
average of three independent experiments.
RPV and Ebp1 protein levels in infected cells
Vero cells were infected with RPV as above, and cells were
lysed in RIPA buffer containing 50 mM Tris HCl, pH 7.4,
300 mM NaCl, 1% Triton X 100, 1% sodium deoxycho-
late, 10% glycerol and 1X protease inhibitor cocktail at the
indicated time points. Fifty lg of the clarified lysate was
resolved by 10% SDS–PAGE, transferred to a nitrocellu-
lose membrane (GE Healthcare, USA) and probed either
with rabbit anti-Ebp1 (1:1,000) or rabbit hyperimmune sera
against whole virus (1:1,000) or mouse anti-actin (1:1,500).
Blots were washed with PBST (PBS with 0.25% Tween
20) and incubated with anti-rabbit/mouse antibody conju-
gated to HRP (1:5,000). After washing three times with an
excess volume of PBST, proteins were detected by devel-
oping the blot with enhanced chemiluminescence reagent
(GE Healthcare, USA).
Indirect immunofluorescence and confocal microscopy
Vero cells were grown on tissue culture chamber slides
(Nunc) to 50% confluence and infected with RPV at an moi
of 5. Forty-eight hours after infection, cells were washed
456 M. Gopinath et al.
123
once with PBS and fixed with 4% paraformaldehyde in
PBS for 20 min at room temperature (RT). Cells were
permeabilized in PBS containing 0.2% Triton X-100 for
5 min at RT. The cells were incubated in blocking buffer
(5% BSA in PBS) for 1 h at RT and washed three times
with PBS. Primary antibodies were added to cells in PBS
containing 3% BSA. The primary antibody combinations
were rabbit anti-Ebp1 (1:100) and mouse hyperimmune
sera against whole virus (1:50) or mouse monoclonal
antibody for RPV N (1:100). Cells were washed three times
with PBS and incubated with TRITC-labeled anti-mouse
antibody and FITC-labeled anti-rabbit antibody. Cells were
visualized using a Zeiss Laser scanning microscope LSM
510.
Co-immunoprecipitation
RPV-infected total cell extracts at 12, 24 and 48 h post-
infection (hpi) were pretreated with 20 ll of 10% protein A
Sepharose CL-4B beads (GE Healthcare, USA) for 1 h at
4C. Co-immunoprecipitation was carried out with anti-
Ebp1 antibodies (1 ll) in the presence of 30 ll of protein A
Sepharose at 4C for 4 h. As a control, an extract prepared
at 48 hpi was subjected to co-immunoprecipitation with
pre-immune serum. The immunoprecipitated complex was
washed three times with buffer containing 50 mM Tris–
HCl, pH 7.4, 300 mM NaCl, 0.1% NP40, 0.05% sodium
deoxycholate and 1 mM PMSF. Beads were suspended in
1X SDS–PAGE loading buffer, boiled for 5 min and loa-
ded onto a 10% SDS–PAGE gel. Western immunoblotting
was carried out with rabbit hyperimmune sera against RPV.
Effect of Ebp1 overexpression on viral mRNA/protein
synthesis in infected cells
Vero cells were transfected with increasing concentrations
(0.5, 1 and 2 lg) of the pCAGGS-Ebp1 construct or with
pCAGGS vector alone (1 lg) using Cellfectin transfection
reagent (Gibco BRL, USA) as per the manufacturer’s
protocol. At 24 h posttransfection, cells were either mock
infected or infected with RPV at an MOI of 5. At 36 h
postinfection, cells were washed once with PBS, and total
cell extract or total cellular RNA was prepared as described
earlier.
Effect of Ebp1 overexpression on virus production
Vero cells were transfected with pCAGGS-Ebp1 or
pCAGGS vector alone as mentioned above, and at 24 h
posttransfection, cells were infected with RPV at an MOI
of 1. Ninety-six hours after infection, infected cells and
supernatants were subjected to three rounds of freeze–thaw
cycles to release the cell-associated virus. Cellular debris
was clarified by centrifugation at 10,000g for 10 min at
4C. Supernatant containing the virus was titred by the
serial endpoint dilution method, and TCID50 values were
calculated by employing the Reed and Muench formula [7].
Results
Ebp1 levels are downregulated upon RPV infection
To test the effect of rinderpest virus infection on Ebp1
expression, Vero cells were infected with RPV. At different
time points, equal amounts of total RNA were loaded onto
a formaldehyde agarose gel (Fig. 1a) and subjected to
northern blot analysis using Ebp1-specific cDNA probes.
The northern blot revealed the presence of a single tran-
script of 1.6 kb in size, corresponding to the full-length
Ebp1 mRNA (Fig. 1b). Upon RPV infection, a gradual
downregulation of Ebp1 transcription was observed, which
was maximal at 60 hpi. Corroborating results were also
obtained when Ebp1 mRNA was quantified by Q-RT PCR
(Fig. 1c). Further, total cell extracts from infected cells at
different time points were electrophoresed on an SDS–
polyacrylamide gel and immunoblotted with antibodies
specific for Ebp1. In agreement with the northern blot
results, the amount of Ebp1 protein was reduced upon virus
infection as early as 24 hpi, which corresponds to the onset
of viral protein synthesis (Fig. 1d, e). At 60 hpi, Ebp1
levels were less than 40% of that of the initial time point
(0 hpi). Under these conditions, the level of a cellular
protein, actin, did not change (Fig. 1f).
Ebp1 protein co-localizes with the RNP complex
Ebp1 has been shown to interact with many cellular pro-
teins, such as Akt, Pak1, Mybbp1a, HDAC2 and Sin 3A [3,
23, 27]. In addition, the interaction between Ebp1 and
polypyrimidine tract-binding protein (PTB) was shown to
be crucial for FMDV IRES activity [19]. Honda et al. [12]
demonstrated that Ebp1 interacts with the PB1 subunit of
influenza virus RNA polymerase and that the PB1 inter-
action site on Ebp1 overlaps with the binding sites for
cellular Akt. Hence, the ability of Ebp1 to interact with
rinderpest virus proteins was tested by immuno co-locali-
zation assay. Virus-infected cells were probed with rabbit
anti-Ebp1 antibody and mouse hyperimmune sera against
the virus at 48 hpi. Ebp1 was seen to co-localize with viral
inclusion bodies, where active transcription and replication
occur (Fig. 2b). In addition, co-localization was also
observed when anti-N antibody was used instead of
hyperimmune sera (Fig. 2c), further confirming that there
is a specific interaction between Ebp1 and the RNP com-
plex in the cytoplasm. No fluorescence signal was observed
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when uninfected cells were probed with viral-protein-spe-
cific antibodies (Fig. 2a). Co-localization of Ebp1 with
viral inclusion bodies suggested that it could be packaged
into mature virions. Hence, virions were purified from
culture supernatants of RPV-infected cells by ultracentri-
fugation as described earlier [8]. The 100,000g supernatant
and the virus pellet were subjected to polyacrylaminde gel
electrophoresis and western blotting, using antibodies to
Ebp1 and viral protein N. As expected, Ebp1 was found to
be present in purified virion, indicating that it is packaged
into mature virus, possibly through interaction with viral
protein/s (Fig. 2d). The S100 fraction showed the presence
of N protein (presumably monomeric), which was released
during cell lysis.
However, immuno-colocalization could not be used to
clearly distinguish which one of the viral proteins interacts
with Ebp1 due to strong intermolecular interactions among
the viral N, P and L proteins in infected cells. Hence, a
co-immunoprecipitation assay was performed with RPV-
infected cell lysate at 48 h postinfection using anti-Ebp1
antibodies. The immunoprecipitated complex was sub-
jected to western blot analysis with a hyperimmune serum
against the whole virus. Ebp1 was found to interact with
RPV N protein in virus-infected cells as early as 24 h
postinfection. This interaction was specific, since the
48 hpi lysate immunoprecipitated with pre-immune sera
did not pull down the N protein (Fig. 2e).
Overexpression of Ebp1 inhibits RPV transcription
and reduces virus yield in vivo
The results described above indicate that RPV infection
downregulates the expression of a key cellular protein,
Ebp1, which associates with the transcription-replication
machinery of the virus. The results also point to the like-
lihood of Ebp1 having an effect on the multiplication of
virus in infected cells. Therefore, the effect of Ebp1
overexpression on genome transcription and virus replica-
tion was tested in vivo. Vero cells were transfected with
increasing concentrations of pCAGGS-Ebp1 construct in
which Ebp1 is cloned under a constitutive CMV promoter.
Increasing the concentration of pCAGGS-Ebp1 led to
increased synthesis of Ebp1 mRNA (Fig. 3a). Endogenous
Ebp1 mRNA could not be detected in cells transfected with
the vector (pCAGGS) alone, possibly due to low level of
expression, which may not get detected when the exposure
time is shorter. Overexpression of Ebp1 at the time of viral
infection (Fig. 3a) led to more than a twofold reduction in
N mRNA synthesis in infected cells (Fig. 3b). A stronger
effect on H mRNA synthesis was observed (Fig. 3c),
suggesting that Ebp1 inhibits overall transcription of viral
mRNA, and this inhibition is not gene-specific. Such
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Fig. 1 Ebp1 mRNA and protein levels in RPV-infected cells. Vero
cells were infected with RPV, and at indicated number of hours
postinfection (hpi), total RNA or total cell extracts were prepared as
described in ‘‘Materials and methods’’. Total RNA was subjected to
formaldehyde-agarose gel electrophoresis and stained with ethidium
bromide to verify equal loading of total RNA (a). Northern blot
analysis of Ebp1 mRNA (b). Real-time PCR analysis of Ebp1 mRNA
levels in infected cells at the indicated time points. The data are an
average of three independent experiments normalized to endogenous
GAPDH levels (c) Total cell extracts prepared from RPV-infected
cells were resolved through 10% SDS–PAGE and western immuno-
blotted with anti-Ebp1 (d), hyperimmune serum against the whole
virus (e) or anti-actin monoclonal antibodies (f) and detected by
enhanced chemiluminescence
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Fig. 2 Ebp1 interaction with
RPV N/N-RNA. Vero cells
were either mock infected (a) or
infected with RPV (b, c), and at
48 h postinfection, cells were
subjected to immuno-
cytochemical analysis with
rabbit anti-Ebp1 and mouse
polyclonal sera against purified
virus (a, b) or rabbit anti-Ebp1
and mouse monoclonal antibody
against RPV N protein (c).
Rinderpest virus was purified
from infected culture
supernatant by
ultracentrifugation. The virus
pellet (lane 2) and S100
supernatant fraction (lane 1)
were probed with a mixture of
anti-Ebp1 and anti-N antibodies
(d). e Clarified lysate from Vero
cells infected with RPV at 12,
24, and 48 hpi (lanes 2–4) was
immunoprecipitated with anti-
Ebp1 antibodies, and the
immunoprecipitate was
electrophoresed and western
immunoblotted with
hyperimmune sera against
whole virus. As a control, Co-IP
was performed using pre-
immune sera with lysate
collected at 48 hpi (lane 1). IgG,
antibody heavy chain. White
arrows indicate the areas of
co-localization
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inhibition was not seen in cells transfected with vector
alone.
The overall transcriptional downregulation of RPV
viral mRNA synthesis may result in the reduction of viral
protein synthesis, which in turn may lead to decreased
virus production. In order to test this hypothesis, viral
proteins synthesis was tested in Ebp1-overexpressing cells
by western blotting. Transfection of increasing amounts
of pCAGGS-Ebp1 led to increased expression of Ebp1
(Fig. 4a). As expected, overall down regulation of viral
protein synthesis (N, P, M and H) was observed in Ebp1-
transfected cells compared to those transfected with the
vector alone (Fig. 4b). L could not be detected in total
cell extract due to its low expression levels. In addition,
overexpression of Ebp1 resulted in a two-log reduction
in RPV titers, suggesting that Ebp1 may play an anta-
gonistic role against RPV infection in infected cells
(Fig. 4d).
Discussion
Viruses, being obligate intracellular pathogens, depend on
many host factors for entry, transcription/replication, mat-
uration and subsequent virus release. In non-segmented
negative-sense RNA viruses, cytoskeletal proteins such as
actin, tublin and profilin have been shown to be associated
with viral RNA-dependent RNA polymerase (RdRp) and
enhance virus transcription in vitro [5]. In addition, trans-
lation initiation factors eIF1a, b, and c and heat shock
Fig. 3 Ebp1 overexpression inhibits virus transcription. Vero cells
were transfected with increasing concentrations (0.5, 1 and 2 lg) of
pCAGGS-Ebp1 (lanes 2–4) or 1 lg of pCAGGS vector alone (lane 1).
At 24 h posttransfection, cells were infected with RPV at an MOI of
5. At 36 h postinfection, total RNA was probed for Ebp1 (a), RPVN
(b) or RPV H(c) mRNA by northern blotting, using gene-specific
probes. d Total RNA was stained with ethidium bromide to ensure
equal loading
Fig. 4 Ebp1 overexpression inhibits virus protein synthesis and
multiplication in vivo. Vero cells were transfected and infected with
RPV as shown in Fig. 3. Lane 1 represents cells that are neither
transfected nor infected. Total cell extracts were prepared at 36 hpi
and western immunoblotted with (a) anti-Ebp1 or (b) anti-RPV.
Cellular actin probed in parallel for equal loading (c). For measure-
ment of viral titers, Ebp1-transfected cells were infected with RPV at
an MOI of 1. ‘‘Mock’’ refers to cells transfected with pCAGGS alone
(1 lg). At 96 h postinfection, virus titres were measured and plotted
as a function of Ebp1 plasmid concentration (d). Titer values are the
average of three independent experiments
460 M. Gopinath et al.
123
protein hsp72 have been shown to associate with viral
RdRp and N proteins of VSV and CDV, respectively [17,
20].
In the present work, we provide evidence to show that
Ebp1 protein affects rinderpest virus mRNA synthesis and
virus yield. The data also show an antagonistic role for
virus at the level of cellular Ebp1 transcription. Ebp1 acts
as a negative regulator of influenza virus transcription and,
subsequently, the virus yield in infected cells [12]. In
addition, Ebp1 also gets upregulated in the initial phase of
influenza virus infection. However, at the onset of PB1
synthesis, Ebp1 protein has been found to reach basal
expression levels (A. Honda, unpublished). In RPV infec-
tion, Ebp1 is downregulated both at the transcriptional and
translational levels. The mechanism by which the Ebp1
mRNA/protein level is downregulated in RPV-infected
cells is still unclear. Cell death is a common phenomenon
in paramyxovirus infection. However, the reduction in
Ebp1 levels at 48 h postinfection is not due to cell death,
since visible cell death commonly occurs around 72 h
postinfection. In addition, endogenous mRNA levels of
GAPDH, as measured by quantitative PCR analysis, did
not change during infection.
Ebp1 is phosphorylated at both Ser 363 and Ser 261, and
phosphorylation at these sites regulates its ability to sup-
press E2F-directed cell cycle-gene transcription as well as
its intracellular degradation [2, 3, 14]. Ebp1 has also been
shown to be ubiquitinated by a cellular protein BRE1,
which is an E3 ligase for H2B mono-ubiquitination [15].
We speculate that virus infection may trigger the dephos-
phorylation of Ebp1 or BRE1-mediated ubiquitination of
Ebp1, which leads to Ebp1 instability in the cell. The
packaging of Ebp1 in the virion has been demonstrated in
the present work. However, it is not clear why Ebp1, being
a negative regulator of virus transcription, is packaged into
the virions.
Ebp1 interacts with an array of cellular factors, such as
Mybbpa, Pak1, Akt1, nucleoplasmin B23 and PKR, and
modulates their activity to suppress cell division in cancer
cell lines [1, 3, 14, 18, 21, 23]. In addition, Ebp1 associates
with Rb, Sin3A and HDAC2 to repress E2F-regulated
genes [25]. In the present study, the co-localization of Ebp1
with the viral RNP complex in cells and its packaging in
purified virions suggested that Ebp1 interacts with RNP-
associated viral protein/s or the N-RNA. Further, co-
immunoprecipitation studies indicated that Ebp1 probably
binds to viral N protein (or N-RNA). However, P could not
be detected in the immunoprecipitate, suggesting that Ebp1
interaction with N protein (N-RNA) may likely eliminate P
binding to assembled N protein. Alternatively, Ebp1 may
interact with the nascent RNA itself [6]. The crystal
structure of Ebp1 reveals the presence of a protein-inter-
acting motif, 354LKALL358, and a lysine-rich motif, which
offers a possibility of direct interaction between Ebp1 and
viral proteins and/or genomic RNA [16]. The association of
Ebp1 with mature ribosome and bcl-2 mRNP complex
further provide evidence for its RNA-binding ability [6,
21].
Since Ebp1 is downregulated upon virus infection, it
was of interest to test the effect of Ebp1 overexpression
on viral transcription in vivo. Overexpression of Ebp1 at
the time of viral infection results in decreased tran-
scription and translation of viral proteins, which in turn
affects the virus yield from infected cells. Similar results
were observed with influenza virus, where Ebp1 was
shown to affect viral transcription both in vivo and in
vitro without affecting the cap binding and endonuclease
activity of the viral polymerase [12]. However, rinderpest
virus transcription takes place exclusively in the cyto-
plasm of infected cells. Ebp1-mediated inhibition may
selectively target genome replication and/or the second-
ary transcription that occurs once viral protein synthesis
begins through its interaction with N/N-RNA. Alterna-
tively, Ebp1 may also affect other cellular factors that
are crucial for viral transcription/replication in vivo. One
candidate for this hypothesis is Akt, which was recently
shown to play a key role in negative-sense RNA virus
replication in vivo [22]. Knockdown of Akt in cells leads
to decreased viral replication, and Akt was shown to
phosphorylate HPIV3 P protein in vitro [22]. Since Ebp1
is a negative regulator of Akt signaling [10, 26], it is
conceivable that, Ebp1 may indirectly regulate viral
transcription/replication by inhibiting Akt activation in
vivo. Ebp1-mediated inhibition of influenza virus tran-
scription as well as RPV virus transcription, as shown in
the present work, leads us to speculate that Ebp1 may
function as an inhibitor for negative-sense RNA virus
replication. However, further studies are needed to con-
firm this hypothesis in other viral systems.
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